Benefit of adjuvant chemotherapy in high-risk colon cancer: A 17-year population-based analysis of 6131 patients with Union for International Cancer Control stage II T4N0M0 colon cancer
Teufel, Andreas, Gerken, Michael, Fürst, Alois, Ebert, Matthias, Hohenthanner, Ina and Klinkhammer-Schalke, Monika (2020) Benefit of adjuvant chemotherapy in high-risk colon cancer: A 17-year population-based analysis of 6131 patients with Union for International Cancer Control stage II T4N0M0 colon cancer. European Journal of Cancer 137, pp. 148-160.Date of publication of this fulltext: 11 Oct 2021 12:44
Article
Alternative links to fulltext
Involved Institutions
Details
| Item type | Article | ||||
| Journal or Publication Title | European Journal of Cancer | ||||
| Publisher: | Elsevier | ||||
|---|---|---|---|---|---|
| Place of Publication: | OXFORD | ||||
| Volume: | 137 | ||||
| Page Range: | pp. 148-160 | ||||
| Date | 2020 | ||||
| Institutions | Medicine > Zentren des Universitätsklinikums Regensburg > Tumorzentrum e.V. Medicine > Institut für Epidemiologie und Präventivmedizin > Tumorzentrum e.V. | ||||
| Identification Number |
| ||||
| Keywords | COLORECTAL-CANCER; IMPROVED SURVIVAL; DUKES B; FLUOROURACIL; LEUCOVORIN; OXALIPLATIN; COMORBIDITY; PREVALENCE; RECURRENCE; EFFICACY; Colon cancer; Survival; Chemotherapy; Registry; Risk factor; Adjuvant | ||||
| Dewey Decimal Classification | 600 Technology > 610 Medical sciences Medicine | ||||
| Status | Published | ||||
| Refereed | Yes, this version has been refereed | ||||
| Created at the University of Regensburg | Yes | ||||
| Item ID | 49731 |
Export bibliographical data
Owner only: item control page
Altmetric
Altmetric